Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP847459.RAhR959yXvSw6ADDQcGmEjVZXQ8cyOSr4MWNJwouDAF_o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP847459.RAhR959yXvSw6ADDQcGmEjVZXQ8cyOSr4MWNJwouDAF_o130_assertion type Assertion NP847459.RAhR959yXvSw6ADDQcGmEjVZXQ8cyOSr4MWNJwouDAF_o130_head.
- NP847459.RAhR959yXvSw6ADDQcGmEjVZXQ8cyOSr4MWNJwouDAF_o130_assertion description "[Epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC) was first recognized in 2004 as a distinct, clinically relevant molecular subset of lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847459.RAhR959yXvSw6ADDQcGmEjVZXQ8cyOSr4MWNJwouDAF_o130_provenance.
- NP847459.RAhR959yXvSw6ADDQcGmEjVZXQ8cyOSr4MWNJwouDAF_o130_assertion evidence source_evidence_literature NP847459.RAhR959yXvSw6ADDQcGmEjVZXQ8cyOSr4MWNJwouDAF_o130_provenance.
- NP847459.RAhR959yXvSw6ADDQcGmEjVZXQ8cyOSr4MWNJwouDAF_o130_assertion SIO_000772 20966921 NP847459.RAhR959yXvSw6ADDQcGmEjVZXQ8cyOSr4MWNJwouDAF_o130_provenance.
- NP847459.RAhR959yXvSw6ADDQcGmEjVZXQ8cyOSr4MWNJwouDAF_o130_assertion wasDerivedFrom befree-2016 NP847459.RAhR959yXvSw6ADDQcGmEjVZXQ8cyOSr4MWNJwouDAF_o130_provenance.
- NP847459.RAhR959yXvSw6ADDQcGmEjVZXQ8cyOSr4MWNJwouDAF_o130_assertion wasGeneratedBy ECO_0000203 NP847459.RAhR959yXvSw6ADDQcGmEjVZXQ8cyOSr4MWNJwouDAF_o130_provenance.